Sera Prognostics, Inc. - Class A Common Stock (SERA)
2.0800
+0.0600 (2.97%)
NASDAQ · Last Trade: Nov 5th, 6:40 PM EST
Sera Prognostics (NASDAQ: SERA) Releases Positive Data from AVERT PRETERM Trial
Sera Prognostics, Inc. (NASDAQ: SERA) is engaged as a health diagnostics company, which is focused around developing treatments and solutions
Via Spotlight Growth · February 15, 2023